$MDLZ
Mondelez International, Inc.

2023 Q2 Form 10-Q Financial Statement

#000110398223000018 Filed on April 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $8.507B $9.166B
YoY Change 16.95% 18.06%
Cost Of Revenue $5.153B $5.720B
YoY Change 11.22% 19.64%
Gross Profit $3.354B $3.446B
YoY Change 27.0% 15.52%
Gross Profit Margin 39.43% 37.6%
Selling, General & Admin $1.843B $1.855B
YoY Change 9.96% 9.57%
% of Gross Profit 54.95% 53.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $290.0M $303.0M
YoY Change 6.23% 10.18%
% of Gross Profit 8.65% 8.79%
Operating Expenses $1.880B $1.855B
YoY Change 12.17% 9.57%
Operating Profit $1.474B $1.505B
YoY Change 59.01% 37.57%
Interest Expense -$334.0M $643.0M
YoY Change 275.28% -806.59%
% of Operating Profit -22.66% 42.72%
Other Income/Expense, Net $71.00M -$95.00M
YoY Change -172.45% -43.45%
Pretax Income $1.161B $2.225B
YoY Change 35.16% 132.01%
Income Tax $268.0M $658.0M
% Of Pretax Income 23.08% 29.57%
Net Earnings $944.0M $2.081B
YoY Change 26.37% 143.39%
Net Earnings / Revenue 11.1% 22.7%
Basic Earnings Per Share $0.69 $1.52
Diluted Earnings Per Share $0.69 $1.52
COMMON SHARES
Basic Shares Outstanding 1.362B shares 1.363B shares
Diluted Shares Outstanding 1.371B shares 1.373B shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.482B $3.539B
YoY Change -22.97% 81.86%
Cash & Equivalents $1.482B $1.939B
Short-Term Investments $705.0M $1.600B
Other Short-Term Assets $2.530B $2.815B
YoY Change 137.34% 146.28%
Inventory $3.825B $3.627B
Prepaid Expenses
Receivables $2.934B $3.502B
Other Receivables $851.0M $810.0M
Total Short-Term Assets $11.62B $12.67B
YoY Change 26.19% 31.73%
LONG-TERM ASSETS
Property, Plant & Equipment $9.944B $9.788B
YoY Change 6.02% 1.24%
Goodwill $23.67B $23.60B
YoY Change 7.09% 4.36%
Intangibles $19.84B $19.81B
YoY Change 8.18% 5.21%
Long-Term Investments $3.245B $3.400B
YoY Change -30.96% -35.3%
Other Assets $3.705B $2.000B
YoY Change 482.55% 402.51%
Total Long-Term Assets $60.40B $60.12B
YoY Change 6.34% 2.98%
TOTAL ASSETS
Total Short-Term Assets $11.62B $12.67B
Total Long-Term Assets $60.40B $60.12B
Total Assets $72.03B $72.79B
YoY Change 9.11% 7.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.740B $7.885B
YoY Change 14.04% 8.89%
Accrued Expenses $3.337B $3.453B
YoY Change 15.87% 15.37%
Deferred Revenue
YoY Change
Short-Term Debt $2.178B $2.461B
YoY Change 260.0% 306.11%
Long-Term Debt Due $901.0M $1.185B
YoY Change 20.78% 57.16%
Total Short-Term Liabilities $18.00B $18.53B
YoY Change 32.58% 31.4%
LONG-TERM LIABILITIES
Long-Term Debt $18.15B $18.56B
YoY Change 1.6% 1.16%
Other Long-Term Liabilities $3.672B $2.668B
YoY Change 77.99% 13.39%
Total Long-Term Liabilities $21.82B $2.668B
YoY Change 957.63% 13.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.00B $18.53B
Total Long-Term Liabilities $21.82B $2.668B
Total Liabilities $43.38B $44.51B
YoY Change 12.78% 11.9%
SHAREHOLDERS EQUITY
Retained Earnings $33.46B $33.04B
YoY Change 6.45% 6.02%
Common Stock $32.15B $32.11B
YoY Change 0.19% 0.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $28.65B $28.23B
YoY Change
Total Liabilities & Shareholders Equity $72.03B $72.79B
YoY Change 9.11% 7.05%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $944.0M $2.081B
YoY Change 26.37% 143.39%
Depreciation, Depletion And Amortization $290.0M $303.0M
YoY Change 6.23% 10.18%
Cash From Operating Activities $850.0M $1.123B
YoY Change 1.67% -0.71%
INVESTING ACTIVITIES
Capital Expenditures $272.0M $223.0M
YoY Change -224.77% 33.53%
Acquisitions -$1.000M
YoY Change -100.07%
Other Investing Activities $886.0M $176.0M
YoY Change 34.24% -325.64%
Cash From Investing Activities $614.0M $636.0M
YoY Change 38.91% -144.14%
FINANCING ACTIVITIES
Cash Dividend Paid $529.0M
YoY Change 7.74%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.036B
YoY Change -55.07%
Cash From Financing Activities -1.782B -$1.757B
YoY Change 44.17% 37.27%
NET CHANGE
Cash From Operating Activities 850.0M $1.123B
Cash From Investing Activities 614.0M $636.0M
Cash From Financing Activities -1.782B -$1.757B
Net Change In Cash -318.0M -$9.000M
YoY Change -857.14% -99.44%
FREE CASH FLOW
Cash From Operating Activities $850.0M $1.123B
Capital Expenditures $272.0M $223.0M
Free Cash Flow $578.0M $900.0M
YoY Change -45.16% -6.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.219
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001103982
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-16483
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Mondelēz International, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
VA
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2284372
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
905 West Fulton Market, Suite 200
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60607
CY2023Q1 dei City Area Code
CityAreaCode
847
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
943-4000
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1361853497 shares
CY2023Q1 us-gaap Revenues
Revenues
9166000000 usd
CY2022Q1 us-gaap Revenues
Revenues
7764000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5720000000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4781000000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
3446000000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
2983000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1855000000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1693000000 usd
CY2023Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
47000000 usd
CY2022Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
164000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
39000000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1505000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1094000000 usd
CY2023Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-19000000 usd
CY2022Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-33000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-95000000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-168000000 usd
CY2023Q1 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
796000000 usd
CY2022Q1 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2225000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
959000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
658000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
210000000 usd
CY2023Q1 mdlz Equity Method Investment Realized Gain Loss On Transaction
EquityMethodInvestmentRealizedGainLossOnTransaction
487000000 usd
CY2022Q1 mdlz Equity Method Investment Realized Gain Loss On Transaction
EquityMethodInvestmentRealizedGainLossOnTransaction
-5000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
35000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
117000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
2089000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
861000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2081000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
855000000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.52
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2023Q1 us-gaap Profit Loss
ProfitLoss
2089000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
861000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
151000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
50000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
6000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-93000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-10000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
52000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
135000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
195000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2224000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1056000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
10000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2214000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1054000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value Including Discontinued Operations
CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
1917000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value Including Discontinued Operations
CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
1923000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
60000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3502000000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3088000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
65000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
59000000 usd
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
810000000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
819000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
3627000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
3381000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
2815000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
880000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
12671000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
10091000000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9131000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9020000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
657000000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
660000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
23604000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
23450000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19810000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19710000000 usd
CY2023Q1 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
1065000000 usd
CY2022Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
1016000000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
451000000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
473000000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
3397000000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
4879000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2000000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1862000000 usd
CY2023Q1 us-gaap Assets
Assets
72786000000 usd
CY2022Q4 us-gaap Assets
Assets
71161000000 usd
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
2461000000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
2299000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1185000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
383000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7885000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7562000000 usd
CY2023Q1 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
2668000000 usd
CY2022Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
2370000000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
785000000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
949000000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3547000000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3168000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
18531000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16731000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
18556000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
20251000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
508000000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
514000000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3648000000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3437000000 usd
CY2023Q1 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
387000000 usd
CY2022Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
403000000 usd
CY2023Q1 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
214000000 usd
CY2022Q4 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
217000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2668000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2688000000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
44512000000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
44241000000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1996537778 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1996537778 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32112000000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32143000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
33040000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
31481000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10814000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10947000000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
634260938 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
630646687 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
26110000000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
25794000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
28228000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
26883000000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
46000000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
37000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28274000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26920000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
72786000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71161000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26920000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
2089000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
135000000 usd
CY2023Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
54000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
409000000 usd
CY2023Q1 us-gaap Dividends Cash
DividendsCash
528000000 usd
CY2023Q1 mdlz Dividends Paid On Noncontrolling Interest And Other Activities
DividendsPaidOnNoncontrollingInterestAndOtherActivities
-13000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28274000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28323000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
861000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
195000000 usd
CY2022Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
60000000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
735000000 usd
CY2022Q1 us-gaap Dividends Cash
DividendsCash
487000000 usd
CY2022Q1 mdlz Dividends Paid On Noncontrolling Interest And Other Activities
DividendsPaidOnNoncontrollingInterestAndOtherActivities
1000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28216000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
2089000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
861000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
303000000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
275000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
38000000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
24000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
199000000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-70000000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
18000000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
155000000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-38000000 usd
CY2023Q1 mdlz Equity Method Investment Realized Gain Loss On Transaction
EquityMethodInvestmentRealizedGainLossOnTransaction
487000000 usd
CY2022Q1 mdlz Equity Method Investment Realized Gain Loss On Transaction
EquityMethodInvestmentRealizedGainLossOnTransaction
-5000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
35000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
117000000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
102000000 usd
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
107000000 usd
CY2023Q1 mdlz Fair Value Adjustment Of Derivatives
FairValueAdjustmentOfDerivatives
-67000000 usd
CY2022Q1 mdlz Fair Value Adjustment Of Derivatives
FairValueAdjustmentOfDerivatives
-13000000 usd
CY2023Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
787000000 usd
CY2022Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-25000000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
590000000 usd
CY2022Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
517000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
232000000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
81000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
216000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
397000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
137000000 usd
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
104000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
517000000 usd
CY2022Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
230000000 usd
CY2023Q1 mdlz Increase Decrease In Pension Assets And Obligations And Postretirement Obligations
IncreaseDecreaseInPensionAssetsAndObligationsAndPostretirementObligations
49000000 usd
CY2022Q1 mdlz Increase Decrease In Pension Assets And Obligations And Postretirement Obligations
IncreaseDecreaseInPensionAssetsAndObligationsAndPostretirementObligations
59000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1123000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1131000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
223000000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
167000000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-1000000 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1418000000 usd
CY2023Q1 mdlz Proceeds From Sale Of Equity Method Investments And Divestiture Of Businesses Net Of Cash Divested
ProceedsFromSaleOfEquityMethodInvestmentsAndDivestitureOfBusinessesNetOfCashDivested
1034000000 usd
CY2022Q1 mdlz Proceeds From Sale Of Equity Method Investments And Divestiture Of Businesses Net Of Cash Divested
ProceedsFromSaleOfEquityMethodInvestmentsAndDivestitureOfBusinessesNetOfCashDivested
66000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
176000000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-78000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
636000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1441000000 usd
CY2023Q1 mdlz Proceeds From Repayments Of Other Short Term Debt
ProceedsFromRepaymentsOfOtherShortTermDebt
156000000 usd
CY2022Q1 mdlz Proceeds From Repayments Of Other Short Term Debt
ProceedsFromRepaymentsOfOtherShortTermDebt
217000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1991000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1036000000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2306000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
399000000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
751000000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
529000000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
491000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
51000000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
60000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1757000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1280000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-11000000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1600000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1948000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3553000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1939000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1953000000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
22000000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1939000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1948000000 usd
CY2023Q1 mdlz Accounts Receivable Sold Under Factoring Program Principal Amount Outstanding
AccountsReceivableSoldUnderFactoringProgramPrincipalAmountOutstanding
858000000 usd
CY2022Q4 mdlz Accounts Receivable Sold Under Factoring Program Principal Amount Outstanding
AccountsReceivableSoldUnderFactoringProgramPrincipalAmountOutstanding
516000000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
39000000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
27000000 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
95000000 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
56000000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
21978000000 usd
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-757000000 usd
CY2023Q1 mdlz Supplier Finance Program Obligation
SupplierFinanceProgramObligation
2500000000 usd
CY2022Q4 mdlz Supplier Finance Program Obligation
SupplierFinanceProgramObligation
2400000000 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
1096000000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1031000000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2680000000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2501000000 usd
CY2023Q1 us-gaap Inventory Gross
InventoryGross
3776000000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
3532000000 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
149000000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
151000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
3627000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
3381000000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
16572000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
16231000000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
7441000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
7211000000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9131000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9020000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
223000000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
290000000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
324000000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
167000000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
244000000 usd
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
249000000 usd
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
2529000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
23450000000 usd
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
154000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
23604000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3389000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2110000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1279000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3354000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
95000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2057000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1297000000 usd
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
18531000000 usd
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
18531000000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
18413000000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
18413000000 usd
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
21920000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2110000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19810000000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
21767000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2057000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19710000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
39000000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
150000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
150000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
150000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
90000000 usd
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
1600000000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
3400000000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
4900000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
35000000 usd
CY2023Q1 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
102000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
117000000 usd
CY2022Q1 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
107000000 usd
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
2461000000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
2299000000 usd
CY2023Q1 mdlz Debt Instrument Reclassification Of Long Term Debt To Short Term Debt Amount
DebtInstrumentReclassificationOfLongTermDebtToShortTermDebtAmount
800000000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
153000000 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
91000000 usd
CY2023Q1 mdlz Gains Losses On Extinguishment Of Debt And Related Expenses
GainsLossesOnExtinguishmentOfDebtAndRelatedExpenses
0 usd
CY2022Q1 mdlz Gains Losses On Extinguishment Of Debt And Related Expenses
GainsLossesOnExtinguishmentOfDebtAndRelatedExpenses
-129000000 usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
58000000 usd
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
52000000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-95000000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-168000000 usd
CY2023Q1 us-gaap Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement
DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
913000000 usd
CY2023Q1 us-gaap Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement
DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
742000000 usd
CY2022Q4 us-gaap Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement
DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
790000000 usd
CY2022Q4 us-gaap Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement
DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
629000000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
171000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
161000000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
659000000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
642000000 usd
CY2022Q1 mdlz Estimated Annual Effective Tax Rate From Continuing Operations
EstimatedAnnualEffectiveTaxRateFromContinuingOperations
0.248
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
20490250 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.31
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
417000000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2455420 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
65.36
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1453616 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
34.75
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
46000000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
109897 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
48.36
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21382157 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.27
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
437000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
49000000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
8000000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
4451674 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
60.12
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2149375 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
66.63
CY2023Q1 mdlz Weighted Average Grant Date Fair Value Stock Granted
WeightedAverageGrantDateFairValueStockGranted
143000000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1598781 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
63.07
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
101000000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
91430 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
60.77
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
4910838 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
61.99
CY2023Q1 mdlz Share Based Compensation Tax Benefit Realized From Stock Awards Vesting
ShareBasedCompensationTaxBenefitRealizedFromStockAwardsVesting
2000000 usd
CY2023Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-30000000 usd
CY2022Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-42000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
135000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
195000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
2000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-4000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
133000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
199000000 usd
CY2023Q1 mdlz Estimated Annual Effective Tax Rate From Continuing Operations
EstimatedAnnualEffectiveTaxRateFromContinuingOperations
0.243
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.296
CY2023Q1 mdlz Effective Income Tax Rate Reconciliation Excluding Impact From Employee Stock Ownership Plan Percent
EffectiveIncomeTaxRateReconciliationExcludingImpactFromEmployeeStockOwnershipPlanPercent
0.230
CY2023Q1 mdlz Effective Tax Rate Net Tax Benefits
EffectiveTaxRateNetTaxBenefits
20000000 usd
CY2023Q1 mdlz Income Tax Reconciliation Tax Settlements And Expiration Of Statute Of Limitations
IncomeTaxReconciliationTaxSettlementsAndExpirationOfStatuteOfLimitations
-30000000 usd
CY2022Q1 mdlz Effective Tax Rate Net Tax Benefits
EffectiveTaxRateNetTaxBenefits
-62000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
2089000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
861000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2081000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
855000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1366000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1389000000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
9000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1373000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1398000000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.52
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 segment
CY2023Q1 us-gaap Revenues
Revenues
9166000000 usd
CY2022Q1 us-gaap Revenues
Revenues
7764000000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
49000000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
27000000 usd
CY2023Q1 mdlz Segment Reporting General Corporate Expenses
SegmentReportingGeneralCorporateExpenses
77000000 usd
CY2022Q1 mdlz Segment Reporting General Corporate Expenses
SegmentReportingGeneralCorporateExpenses
50000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
39000000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32000000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
21000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1505000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1094000000 usd
CY2023Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-19000000 usd
CY2022Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-33000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-95000000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-168000000 usd
CY2023Q1 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
796000000 usd
CY2022Q1 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2225000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
959000000 usd
CY2023Q1 us-gaap Revenues
Revenues
9166000000 usd
CY2022Q1 us-gaap Revenues
Revenues
7764000000 usd

Files In Submission

Name View Source Status
mdlz-20230331_lab.xml Edgar Link unprocessable
mdlz-20230331_cal.xml Edgar Link unprocessable
mdlz-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001103982-23-000018-index-headers.html Edgar Link pending
0001103982-23-000018-index.html Edgar Link pending
0001103982-23-000018.txt Edgar Link pending
0001103982-23-000018-xbrl.zip Edgar Link pending
ex102_33123.htm Edgar Link pending
ex103_33123.htm Edgar Link pending
ex104_33123.htm Edgar Link pending
ex311_33123.htm Edgar Link pending
ex312_33123.htm Edgar Link pending
ex321_33123.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
image_0a.jpg Edgar Link pending
mdlz-20230331.htm Edgar Link pending
mdlz-20230331.xsd Edgar Link pending
mdlz-20230331_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
mdlz-20230331_pre.xml Edgar Link unprocessable
mdlz-20230331_htm.xml Edgar Link completed
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending